Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for Monthly Verification of QC Working Standards – V 2.0

Posted on By

API Manufacturing: SOP for Monthly Verification of QC Working Standards – V 2.0

Standard Operating Procedure for Monthly Verification of QC Working Standards in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/159/2025
Supersedes SOP/API/159/2022
Page No. Page 1 of 11
Issue Date 14/04/2025
Effective Date 16/04/2025
Review Date 14/04/2026

1. Purpose

To define a standard procedure for the monthly verification of Quality Control (QC) working standards used in analytical testing of raw materials, intermediates, and Active Pharmaceutical Ingredients (APIs) to ensure their ongoing suitability, potency, and compliance with regulatory standards.

2. Scope

This SOP applies to all working standards currently in use in the QC laboratory of

the API manufacturing unit. It includes physical verification, documentation, and suitability testing for continued analytical use.

3. Responsibilities

  • QC Analyst: Perform monthly verification and record results in the Working Standards Verification Log.
  • QC Store Officer: Maintain inventory of working standards and track expiry/retest dates.
  • QA Officer: Review verification reports and authorize continued use or withdrawal.

4. Accountability

The Head of QC is accountable for ensuring that only qualified and verified working standards are used for analytical purposes and that verification logs are up to date.

See also  API Manufacturing: SOP for Seeding Techniques in Crystallization - V 2.0

5. Procedure

5.1 Identification and Traceability

  1. Each working standard must be assigned a unique identification code (e.g., WS/YY/XXX).
  2. The label on each container shall include:
    • Name of the compound
    • Source and batch number
    • Date of preparation
    • Purity
    • Assigned expiry/retest date
    • Storage conditions

5.2 Verification Frequency and Planning

  1. Verify all active working standards on a monthly basis, preferably in the first week of each month.
  2. Maintain a Master Verification Calendar (Annexure-1) to track due dates for all standards.
  3. Review the verification schedule at the start of each month to plan testing.

5.3 Types of Verification

  1. Perform the following tests for monthly verification:
    • Physical appearance (color, texture, clumping)
    • Assay or potency (against reference standard)
    • Loss on drying (if applicable)
    • Identification (IR or UV, as applicable)
  2. Record all results in the Working Standards Verification Log (Annexure-2).
  3. If retest is not possible due to insufficient quantity, inform QA and discontinue use.

5.4 Criteria for Acceptability

  1. The working standard shall be considered suitable if:
    • Assay/potency is within ±2% of labeled value
    • No physical degradation is observed
    • Results of identification are positive
  2. If any deviation is observed, report immediately to QC Head and QA.
  3. Withdraw standard from use and quarantine until investigation is complete.
See also  API Manufacturing: SOP for Cleaning Procedure for Storage Containers - V 2.0

5.5 Documentation and Records

  1. Make entries in the following logs:
    • Working Standards Master Register (Annexure-3)
    • Verification Log (Annexure-2)
    • Retest Calendar (Annexure-1)
  2. Retain all verification worksheets and raw data for a minimum of 5 years.
  3. Attach calibration certificate or source document (e.g., CoA) during initial qualification.

5.6 Requalification or Replacement

  1. Requalify working standards:
    • At defined retest intervals (e.g., every 3 or 6 months)
    • Upon any change in source/reference standard
    • After storage excursions (temperature, humidity)
  2. In case of expiry or failure, prepare a new lot of working standard and assign a new ID.
  3. Document withdrawal and destruction using the Standard Withdrawal Form (Annexure-4).

5.7 Labeling Requirements

  1. All labels must be waterproof, legible, and affixed securely.
  2. Labels should be updated if:
    • Purity changes post-assay
    • Retest date is extended
    • Any requalification is done

6. Abbreviations

  • QC: Quality Control
  • QA: Quality Assurance
  • WS: Working Standard
  • CoA: Certificate of Analysis

7. Documents

  1. Master Verification Calendar (Annexure-1)
  2. Working Standards Verification Log (Annexure-2)
  3. Working Standards Master Register (Annexure-3)
  4. Standard Withdrawal Form (Annexure-4)
See also  API Manufacturing: SOP for Preparation of HPLC Mobile Phase - V 2.0

8. References

  • ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
  • 21 CFR Part 211.84 – Testing and Approval or Rejection of Components
  • WHO TRS No. 1019 – Annex 4

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Master Verification Calendar

WS ID Compound Retest Due Status Remarks
WS/25/001 Paracetamol 30/04/2025 Pending Scheduled for Week 4

Annexure-2: Working Standards Verification Log

Date WS ID Assay (%) LOD (%) ID Test Verified By Status
10/04/2025 WS/25/001 99.6 0.3 Pass Rajesh Kumar Accepted

Annexure-3: Working Standards Master Register

WS ID Compound Source Preparation Date Purity (%) Expiry
WS/25/001 Paracetamol IP Reference Std 15/01/2025 99.6 15/07/2025

Annexure-4: Standard Withdrawal Form

Date WS ID Reason Action Taken Approved By
14/04/2025 WS/24/112 Expired Disposed as per SOP Sunita Reddy

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial SOP Release New Implementation QA Head
14/04/2025 2.0 Added LOD and monthly calendar format Audit Suggestion QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Creams: SOP for Inline Particle Size Monitoring – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Compatibility Studies of Container Closure Systems – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version